We send the latest information from SMC Laboratories.
We are pleased to announce that SMC Laboratories will be virtually attending the BIO One-on-One PartneringTM in Bio Asia Taiwan from July 27th to 31th. So, you can conduct web meeting using Zoom. If you are attending the event and are interested in our services or STAMTM mice, please feel free to contact us. …
Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) model at the 29th convention of The Japanese Society for the Research of Hepatic Cells, which is to be held on August 25th and 26th. This will be the first time that our company has presented at an event…
We will join BIO KOREA 2022 International Convention, one of the biggest bio-health conventions in Asia. BIO KOREA 2022 offers business and global partnership opportunities for executives from pharmaceutical/biotechnology companies through business forums, exhibition, conference, and investment fair. We would love to have the opportunity to meet with you virtually and introduce…
We are pleased to announce that SMC Laboratories will be virtually attending the BIO One-on-One Partnering event next week from Monday, January 10th to Friday, January 14th. If you are interested in attending BIO Partnering, please visit their website for more information on the event and how to register.
We are pleased to announce the acceptance of our abstracts, “Molecular Pathogenesis of Non-Alcoholic Steatohepatitis (NASH) through the Dysregulation of Metabolic Organ Network in the NASH-HCC Model Mouse Treated with Streptozotocin-High Fat Diet” and “RNA-Seq Analysis of Liver from NASH-HCC Model Mouse Treated with Streptozotocin-High Fat Diet“—KDDW 2021, to be held from November 18 to 20,…
We are joining BioPharm America™ Digital, one of the most famous virtual biotech partnering and education events. This digital event creates opportunities of exchange between executives from pharmaceutical/biotechnology companies of every size and stage, investors, and academic institutions. BioPharm America™ Digital gives opportunity for ventures within the life science realm to be explored through…
We will be attending the annual 24th BioJapan from Wednesday, October 13th, 2021 – Friday, October 15th, 2021 (10/13 – 15, 2021) at the Pacifico Yokohama Convention Center! We are also going to give a formal convention presentation on the third day, Friday, October 15th, 2021 (10/15/2021). We would love to have the opportunity…
We are pleased to announce the acceptance of our abstract, “RNA-seq Analysis of Liver from Diabetic and NASH Model Mouse Treated with Streptozotocin, High-Fat Diet”, for presentation in the category “Integrated Physiology—Liver” at the 81st Annual Meeting of the American Diabetes Association, to be held from June 25 to 29, 2021. The poster will…
We are joining the world’s largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. The virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering, educational resources, and the valuable insights for research and development. Main Conference Webpage SMC Laboratories Inc's…
Our clients presented data on treatment of NASH using STAMTM model at the EASL ~The Digital International Liver CongressTM 2020~ (August 27-29). For detailed information, see the below URL. https://ilc-congress.eu/wp-content/uploads/2020/08/digital-ilc-2020-abstract-book-20-august.pdf Poster #FRI105 Therapeutic efficacy of the chitotriosidase inhibitors in STAM model of non-alcoholic steatohepatitis Institution: OncoArendi Therapeutics SA (Paland) Poster #FRI119 Novel…